Samuel Kintz, President and CEO: Enliven Therapeutics ELVN Planned sale · Filed 01/08

Trade details

Type: Planned sale notice
Stock: Enliven Therapeutics ELVN
Person: Samuel KintzPresident and CEO
Planned sale date: 26/01/08
Filed: 26/01/08

More to sell after $621.3K in 3 months

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/09~02/07

Samuel Kintz's recent trades

Samuel KintzPresident and CEO
Planned sale10b5-1 planEnliven Therapeutics
Planned sale10b5-1 plan
Enliven Therapeutics
ELVN
$2M
75,000 sh
$2M
Filed 02/17
Traded 02/17
Samuel KintzPresident and CEO
Planned sale10b5-1 planEnliven Therapeutics
Planned sale10b5-1 plan
Enliven Therapeutics
ELVN
$1.7M
75,000 sh
$1.7M
Filed 01/09
Traded 01/09
Samuel KintzPresident and CEO
Planned sale10b5-1 planEnliven Therapeutics
Planned sale10b5-1 plan
Enliven Therapeutics
ELVN
$84.6K
5,000 sh
$84.6K
Filed 25/12/17
Traded 25/12/17
Samuel KintzPresident and CEO
Sell10b5-1 planEnliven Therapeutics
Sell10b5-1 plan
Enliven Therapeutics
ELVN
$272.8K
12,500 sh
$272.8K
Filed 25/11/19
Traded 25/11/17
Samuel KintzPresident and CEO
Planned sale10b5-1 planEnliven Therapeutics
Planned sale10b5-1 plan
Enliven Therapeutics
ELVN
$275.9K
12,500 sh
$275.9K
Filed 25/11/17
Traded 25/11/17

Samuel Kintz, CEO — plans to sell 82,500 sh of Enliven Therapeutics ELVN · $1.3M · around 01/08 · 10b5-1 plan | Whalegun